SAN DIEGO, Jan. 7, 2018 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, today announced that Christopher O’Brien, M.D., Chief Medical Officer, has notified the Company he plans to retire in…
